Aim of the webinar:
The webinar speakers will discuss the definitions and frequencies of weak or discrepant RhD phenotypes and the serological and genetic mechanisms for how they arise. The speakers will describe when to perform RHD genotyping in patients to resolve phenotyping problems; how RHD molecular results in these cases vary by race, ethnicity and world regions; and how to apply genotyping to RhD management of obstetrical patients and transfusion recipients.
Level of education required:
Intermediate (practical application)
What prior knowledge is required?
No prior knowledge is required for this webinar
Target audience
Blood centre and transfusion practitioners, nurses, and clinicians whose patients may require massive
transfusions.
The Speakers
